ERBB2 c.2009T>G ;(p.V670G)

Variant ID: 17-37879634-T-G

NM_004448.2(ERBB2):c.2009T>G;(p.V670G)

This variant was identified in 3 publications

View GRCh38 version.




Publications:


The circulating tumor DNA (ctDNA) alteration level predicts therapeutic response in metastatic breast cancer: Novel prognostic indexes based on ctDNA.

Breast (Edinburgh, Scotland)
Liu, Binliang B; Hu, Zheyu Z; Ran, Jialu J; Xie, Ning N; Tian, Can C; Tang, Yu Y; Ouyang, Quchang Q
Publication Date: 2022-10

Variant appearance in text: ERBB2: V670G
PubMed Link: 35926241
Variant Present in the following documents:
  • mmc1.xlsx, sheet 1
View BVdb publication page



Does breast carcinoma belong to the Lynch syndrome tumor spectrum? - Somatic mutational profiles vs. ovarian and colorectal carcinomas.

Oncotarget
Porkka, Noora K NK; Olkinuora, Alisa A; Kuopio, Teijo T; Ahtiainen, Maarit M; Eldfors, Samuli S; Almusa, Henrikki H; Mecklin, Jukka-Pekka JP; Peltomäki, Päivi P
Publication Date: 2020-04-07

Variant appearance in text: ERBB2: 2009T>G; Val670Gly
PubMed Link: 32292574
Variant Present in the following documents:
  • oncotarget-11-1244-s005.xlsx, sheet 1
View BVdb publication page



Chemotherapy Modulates Endocrine Therapy-Related Resistance Mutations in Metastatic Breast Cancer.

Translational Oncology
Zhou, Dabo D; Ouyang, Quchang Q; Liu, Liping L; Liu, Jingyu J; Tang, Yu Y; Xiao, Mengjia M; Wang, Yikai Y; He, Qiongzhi Q; Hu, Zhe-Yu ZY
Publication Date: 2019-05

Variant appearance in text: ERBB2: V670G
PubMed Link: 30893632
Variant Present in the following documents:
  • Main text
  • main.pdf
View BVdb publication page